Skip to main content

Table 2 Univariate analysis of prognostic factors in cervical cancer patients

From: PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway

Variables

Univariable analysis

Hazard ratio

95 % Confidence Interval

P value

Age

   

  < 65 vs ≥ 65

1.261

(0.714-1.906)

0.4362

Tumor size (cm)

   

  < 4 vs ≥4

1.179

(0.706-1.942)

0.4523

HPV

   

 Positive vs Negative

0.875

(0.437-1.691)

0.7831

Tumor histology

   

 Squamous vs Others

0.696

(0.354-1.342)

0.2874

FIGO stage

   

 Ib-IIa vs IIb-IIIa

2.226

(1.416-3.752)

0.0026*

LN metastasis

   

 Positive vs Negative

2.042

(1.318-3.265)

0.0048

Distant metastasis

   

 Positive vs Negative

1.660

(0.980-2.945)

0.0522

Histological grade

   

 Poor vs Well/moderate

1.762

(1.130-2.706)

0.0375

PAK4 expression

   

 High vs Low

2.217

(1.435-3.562)

0.0014

  1. *: with significance